Research progression of raltitrexed in the treatment of gastric cancer
10.3760/cma.j.issn.1673-422X.2016.07.014
- VernacularTitle:雷替曲塞治疗胃癌的研究进展
- Author:
Song XUE
;
Yingxia CHEN
- Publication Type:Journal Article
- Keywords:
Stomach neoplasms;
Drug therapy;
Raltitrexed
- From:
Journal of International Oncology
2016;43(7):535-537
- CountryChina
- Language:Chinese
-
Abstract:
Raltitrexed is a specific inhibitor of thymidylate synthase,and has been confirmed that ralti-trexed has no cross tolerance with 5-fluorouracil.Studies have shown that raltitrexed-based combination chemo-therapy has a beneficial effect on the treatment of advanced gastric cancer,and well tolerance,which is worthy of clinical use.
